Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,491 | 608 | 638 | 660 | 825 |
| Receivables | 963 | 762 | 1,095 | 1,025 | 993 |
| Inventories | 162 | 651 | 390 | 1,272 | 710 |
| TOTAL | $3,842 | $3,442 | $3,547 | $4,865 | $4,478 |
| Non-Current Assets | |||||
| PPE Net | 7,074 | 6,976 | 7,259 | 7,654 | 7,784 |
| Investments And Advances | 5,785 | 6,024 | 6,026 | 6,027 | 6,028 |
| Intangibles | 1,294 | 1,247 | 1,267 | 1,289 | 1,289 |
| Other Non-Current Assets | 864 | 714 | 726 | 745 | 753 |
| TOTAL | $15,017 | $14,961 | $15,277 | $15,715 | $15,854 |
| Total Assets | $18,859 | $18,403 | $18,825 | $20,580 | $20,332 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 217 | 538 | 677 | 1,390 | 1,354 |
| Accounts payable and accrued liabilities | 331 | 171 | 167 | 426 | 175 |
| Accrued Expenses | 300 | 248 | 198 | 366 | 422 |
| Other current liabilities | 551 | 323 | 243 | 412 | 497 |
| TOTAL | $3,199 | $1,281 | $1,285 | $2,594 | $2,448 |
| Non-Current Liabilities | |||||
| Long Term Debt | 802 | 2,448 | 2,430 | 2,443 | 2,124 |
| Other Non-Current Liabilities | 906 | 1,057 | 1,033 | 991 | 1,033 |
| TOTAL | $1,712 | $3,463 | $3,446 | $3,464 | $3,134 |
| Total Liabilities | $4,911 | $4,744 | $4,731 | $6,058 | $5,582 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,336 | 17,967 | 16,340 | 15,375 | 14,860 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -50,142 | -48,827 | -48,340 | -47,717 | -47,334 |
| Other shareholders' equity | -1,797 | -1,685 | -1,541 | -1,339 | -1,398 |
| TOTAL | $13,948 | $13,659 | $14,094 | $14,522 | $14,750 |
| Total Liabilities And Equity | $18,859 | $18,403 | $18,825 | $20,580 | $20,332 |